They add that this method will likely work equally well with tamoxifen, the world’s most commonly used breast cancer drug. Both fulvestrant and tamoxifen are used in women with estrogen-receptor-positive metastatic breast cancer
Headline News Archive
Click on title to read the full article.
FDA Expands Use of Approved Breast Cancer Drug
January 29, 2020
U.S. Food and Drug Administration today approved Tykerb (lapatinib) in combination with Femara (letrozole) to treat hormone positive and HER2-positive advanced breast cancer in postmenopausal women for whom hormonal therapy is indicated.
Dual HER2-blockade regimen boosts overall survival in refractory metastatic breast ca
January 21, 2021
By Caroline Helwick, Oncology NEWS International
SAN ANTONIO—The targeted combination of lapatinib (Tykerb) plus trastuzumab (Herceptin) led to a median overall survival of 14 months in women with refractory metastatic breast cancer, according to an updated analysis of the phase III EGF104900 trial
Women with breast cancer may benefit from autologous stem cell transplantation
January 12, 2021
By Health & Medicine
Compared to conventional chemotherapy, autologous stem cell transplantation can extend “event-free survival” for breast cancer patients. Clinical trials provide proof of this for breast cancer with and without distant metastases.
Lombardi researchers find investigational agent reduces tumor resistance to breast cancer therapy
January 5, 2021
By Karen Mallet, Georgetown University Medical Center
Researchers find out why estrogen-positive tumors stop responding to commonly used drugs, pointing a way to new therapies
Washington, DC – Researchers at Georgetown Lombardi Comprehensive Cancer Center have found a way to cleverly override signals that tell breast cancer cells to keep surviving in the face of anticancer treatment. The investigational agent they used renews the sensitivity of these breast cancer cells to treatment by fulvestrant (Faslodex®) which had stopped working.
Tumours can re-seed themselves
January 3, 2021
By The International News
Tumours cannot only spread through the body by sending out tiny cells called seeds, but they can re-seed themselves, researchers said in a report that may help explain why tumours grow back even after they are removed.
They said their findings, published in the journal Cell, may also help lead to the development of new drugs to stop the process of cancer spread, or metastasis.
Headline News Archive
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- October 2007
- September 2007